fda warning letters compounded semaglutide september 2025 issued 30 to telehealth companies for false and misleading claims about GLP-1 products. This marks the second round of enforcement action since the agency's crackdown on misleading There's lots going on this
Description
Our program emphasizes regular check-ins and coaching to keep you on track
The crystal structures of un-acylated liraglutide and semaglutide are almost identical to GLP-1 (37)
Others leave out important context
GLP-1 receptors are located in brain regions controlling reward, motivation, and dopamine signaling
Brands launching GLP-1 Friendly foods across retail and foodservice As GLP-1 medications reshape eating habits, several food companies are launching products specifically designed to support smaller portions, higher satiety, and better nutritional balance
